Matthew R Narlesky Source Confirmed

OverviewAI-generated summary

Matthew R. Narlesky's research focuses on the pharmacological management of psychiatric and behavioral conditions, particularly in patient populations with complex medical histories. His work includes investigating the use of specific medications, such as methylphenidate, for managing attention deficits and behavioral dyscontrol in conditions like Smith-Magenis Syndrome. Narlesky has also explored the relative safety profiles of substances like psilocybin in the treatment of psychiatric disorders through systematic reviews. His publications address challenges in initiating psychotropic treatment for individuals with conditions such as Alpha-Gal Syndrome and examine the denial of pregnancy in patients with a history of pseudocyesis.

His scholarship metrics include an h-index of 3 with 6 total publications and 60 total citations. Narlesky has collaborated with researchers from Harding University Main Campus, including Fahim Rasul, Suporn Braaten, and Robert G. Wooten, with whom he shares one publication each. His most recent publication was in 2022, indicating recent activity in his field.

Metrics

• h-index: 3
• Publications: 6
• Citations: 60